Mr. Beach is a successful entrepreneur and engineer. Since 2005, he has extensive experience designing, developing, and manufacturing catheter-based devices, specifically for peripheral vascular interventions. As the head of Research and Development and also as the Chief Operating Officer for Flexible Stenting Solutions Inc., he invented a novel fracture resistance femoropopliteal stent and was instrumental in bringing it from concept through initial clinical use and regulatory approvals, ultimately to a successful acquisition by Cordis Corporation in 2013.
Additionally, in 2012, he co-founded a contract manufacturer of medical device components in India, MAJIK Medical Solutions Pvt. Ltd (MAJIK), and is still an active director.
Prior to 2005, Mr. Beach was involved in engineering, product development and manufacturing across multiple industries, including aerospace, capital equipment design, consumer products, and electronics packaging. This broad, more generalist engineering background has been very beneficial in applying different thinking to interventional catheter devices.
Dr. Gary Ansel
Chief Medical Advisor
Dr. Ansel is an internationally renowned interventional expert, both in peripheral vascular and cardiovascular procedures. He has served as an invited faculty member at many of the largest cardiovascular conferences and medical meetings around the world.
Dr. Ansel was the Associate Medical Director of the OhioHealth Research and Innovation Institute. He has served as the primary investigator for numerous national and international research trials helping to develop improved patient care to those suffering with peripheral and cardiovascular disease. Dr. Ansel developed numerous industry sponsored training courses attended by national and international physicians.
Dr. Ansel has been the System Medical Chief for the OhioHealth Vascular Program – and formed and directed the OhioHealth Vascular Institute, the first multi-institution, multi-specialty Vascular Institute in the United State. Dr Ansel’s academic affiliation is with the Department of Internal Medicine at the University of Toledo Medical Center, Toledo, Ohio where he has been an Assistant Clinical Professor of Medicine.
Dr. Ansel was a founding board member of the Vascular Interventional Advances Conference (VIVA), a non-profit organization dedicated to the integrated education and research of vascular disease.
Dr. Ansel created the Ansel Sheath (Cook Medical, Bloomington, IN) which has been the leading interventional vascular access device in the field. He has numerous patents and has been a consultant for numerous small and large medical device companies.
Dr. Ansel has published extensively in the field of Cardiovascular Medicine. He has contributed to journals such as The New England Journal of Medicine, Circulation, Journal of Endovascular Therapy, Catheter and Cardiovascular Intervention and The American Journal of Cardiology as well as authored many medical book chapters.
Dr. Michael R. Jaff
Chief Medical Advisor
Michael R. Jaff, DO is a professor of medicine at Harvard Medical School. He was the President of Newton-Wellesley Hospital from October 2016-December 2019. Prior to that, Dr. Jaff was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital. He is an expert in all aspects of vascular medicine, including peripheral artery disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine.
He is the founder of VasCore, the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. VasCore has participated in trial design and independent analysis of vascular laboratory images for over 200 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries.
Dr. Jaff has published extensively in the field of Vascular Medicine with over 300 peer-reviewed publications and 10 textbooks, is the Past-President of the Society for Vascular Medicine and Biology and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention, and is a registered physician in vascular interpretation (RPVI).
In November 2011, Dr. Jaff became an alumnus of Harvard Business School after completing the General Management Program.